Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New 2013 iPSC Industry Report Details Market Trends, Metrics and Financials

Published: Friday, September 20, 2013
Last Updated: Friday, September 20, 2013
Bookmark and Share
Report provides strategic insights that guide the decision-making of companies that develop and manufacture induced pluripotent stem cell research products.

BioInformant Worldwide, LLC, has recently released the market intelligence report titled “The Complete 2012-13 Induced Pluripotent Stem Cell (iPSC) Industry Report.”  

The market intelligence report presents financial metrics for the Induced Pluripotent Stem Cell Industry, as well as key findings discovered from surveying a global audience of iPSC researchers (293 respondents). It reveals iPSC product and industry trends with five-year projections; informs about iPSC grants, patents and publications; identifies profitable opportunities for producers of iPSC products, and presents critical insights into future tools that iPSC scientists will require. In addition, it clearly denotes preferred species for iPSC research, analyzes the competitive environment for iPSC research products, and breaks down market share by competitor – providing an overall view of the iPSC product landscape. 

iPSCs are adult stem cells that have been transformed into embryotic-like stem cells through the manipulation of gene expression and similar methods. Despite some initial concerns, induced pluripotent stem cells (iPSC) are now sold by more than half (53.4%) of U.S. research product companies and 38.7% of research product companies worldwide.

"It is clear that iPSC products are in high demand within the scientific community. Currently, it is difficult for stem cell research product suppliers, like BD BioSciences, Life Technologies, and others, to know what products iPSC scientists will demand in 2013 and beyond. The needs of scientists are constantly changing, so this market intelligence report reveals profitable opportunities for providers of iPSC research products to pursue,” says BioInformant. 

For the past five decades, stem cell research has provided insights to the inner workings of the body and cell regeneration. “Therapeutic applications of iPSCs represent the future of medicine," says BioInformant. The scientific community believes that one day stem cell research will assist in finding viable treatments for crippling diseases such as Parkinson’s, Alzheimer’s, spinal cord injuries and more.  

“This is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. This is a lucrative and rapidly expanding market,” explains BioInformant.  “The study will help you understand your key strengths relative to the competition.”

The study is backed by a 100% money back guarantee, to ensure that the strategies, findings and tools are found helpful.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flow Chemistry Market by Reactor Type, Application & Geography - Trends & Forecast to 2018
Market estimated at $709.5 million and expected to reach $1,216.1 million by 2018 growing at CAGR of 9.4%.
Friday, April 11, 2014
DNA and RNA Isolation Techniques: Market Developments, Growth Areas and Opportunities
Report highlights that the use of kit-based isolation methods is expected to grow by 16% in the next three years.
Friday, October 18, 2013
Antibiotic Resistance 2013: A Global Market Study
Just ten antibiotic classes are being used to treat 86% of all bacterial infections.
Friday, October 18, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
10X Genomics Releases Linked-Read Data from NIST Genome Samples
Genome in a Bottle Consortium data submission for webinar presentation and public availability.
Study Sheds Light on the Causes of Cerebral Palsy
Wider use of genetic testing in children with CP should be considered.
Pitt Researchers to Monitor Resistance to HIV Drugs in Africa
Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.
Environmental Epigenetics Affects Disease, Evolution
Researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism’s DNA sequence.
Critical New Insights on DNA Repair
The enzyme fumarase is key to reversing genetic damage leading to cancer and therapy resistance.
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Nanoparticles Used to Breach Mucus Barrier in Lungs
Proof-of-concept study conducted in mice is a key step toward better treatments for lung diseases.
New Biosensors for Managing Microbial ‘Workers’
Researchers at Harvard’s Wyss Institute have unveiled new biosensors that enable scientists to more effectively control and 'communicate with' engineered bacteria.
Researchers Identify Protein in Mice that Helps Prepare for Healthy Egg-sperm Union
Protein RGS2 plays a critical role in preserving the fertilizability of the ovulated egg.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!